AXGN vs JPM Stock Comparison

AXGN currently leads JPM in this stock comparison, with AIQ scores of 65 vs 64. The clearest difference is value, while JPM has the stronger risk resilience profile.

Market data as of Nov 18, 2026 market close· AIQ score gap 1 points
AXGN
Healthcare
vs
JPM
Financial Services
AXGN
AxoGen, Inc.
Leads
Price
$56.95
Day move
+2.85%
AIQ Score
65/100
Best edge
Value
Sector
Healthcare
JPM
JPMorgan Chase & Co.
Price
$324
Day move
-1.77%
AIQ Score
64/100
Best edge
Risk Resilience
Sector
Financial Services

What is the main difference between AXGN and JPM?

AXGN leads the current stock comparison as AxoGen, Inc., with the clearest separation coming from value and the broader AIQ evidence mix.

AlgovestIQ AIQ Comparison

AxoGen, Inc. vs JPMorgan Chase & Co.

Data as of Nov 18, 2026· market close· Cross-sector · Healthcare vs Financial Services· Coverage 65/66 fields· High confidence
AIQ VerdictFragileAIQ Comparison Conviction 3/10

AXGN leads

AXGN leads by 1 AIQ points, primarily on Value and Momentum, having only recently taken the lead back from JPM. Wall Street currently favors JPM on target upside.

Fragile: 3 of 6 evidence groups support AXGN, the lead recently changed hands, and its current signal state is conflicted.

Evidence agreement: 3 of 6Comparison trend: Reversed
AXGN

AxoGen, Inc.

Leads
AIQ Score
65/100
AIQ Edge Score
7/10
JPM

JPMorgan Chase & Co.

AIQ Score
64/100
AIQ Edge Score
8/10

The Algovestiq AIQ Score currently favors AXGN over JPM, 65 versus 64 as of Nov 18, 2026. AXGN's advantage is driven primarily by stronger value and momentum, while JPM holds the stronger risk resilience profile. AXGN also shows the stronger technical structure relative to its 50-day moving average, though analyst target upside currently favors JPM. 3 of 6 covered evidence groups favor AXGN today, and the comparison is rated Fragile on stability: the AIQ gap is narrow at 1 points. AXGN lead: Reversed — JPM led by 7 AIQ points 30 sessions ago; AXGN now leads by 1.

Compare AxoGen, Inc. and JPMorgan Chase & Co. across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.

Currently unavailable

Performance over time

Total return with distributions reinvested, from daily closes.

AXGN
+463.3%
JPM
+123.4%

Total return comparison

Growth of $10,000, distributions reinvested

AXGN $56,330 · JPM $22,337

Split-adjusted closes; each distribution is reinvested at the close on its ex-dividend date. Taxes and trading costs are not modeled.

Compare AXGN and JPM against another ticker

Open a multi-ticker workspace without changing this focused pair page.

Basic: 2 symbols·Explorer: 3 symbols·Pro and Premium: 5 symbols·Your limit: 2

AIQ Factor Divergence

Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.

AXGN advantage
0
JPM advantage
  • Risk Resilience55 vs 87
    JPM +32
  • Value33 vs 10
    AXGN +23
  • Quality70 vs 86
    JPM +16
  • Momentum82 vs 67
    AXGN +15

3 of 6 evidence groups favor AXGN. AXGN’s edge is concentrated in value and momentum; JPM keeps a meaningful risk resilience edge.

What changed since the last close

Latest scored session 2026-11-18, compared against the prior scored session 2026-11-17.

AXGN+3 AIQ

Largest factor move: Momentum +8

New signals

  • Low Volume Rally Warning — bearish, volume, short horizon (0.66x)
JPM0 AIQ

No factor moved materially.

New signals

  • Drawdown Recovery Signal — bullish, risk_regime, long horizon (-9.0%)
  • MACD Histogram Expanding Bullish — bullish, momentum, short horizon

The lead changed hands: AXGN moved ahead of JPM in the latest session.

Deeper signal detail for each name lives on its own signals page — AXGN and JPM both carry a full feed there.

The central trade-off

AXGN (AxoGen, Inc.): the stronger current systematic profile, led by value and momentum.

JPM (JPMorgan Chase & Co.): the counter-case, on risk resilience, quality, analyst expectations.

The AIQ Score and Wall Street therefore point in different directions on this pair.

Which one fits your objective

The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.

Balanced

AXGN

AXGN on the overall AIQ Score, which weights Quality and Value most heavily.

Growth

AXGN

AXGN on combined revenue and EPS growth.

Value

AXGN

AXGN on the peer-relative Value factor, by 23 points.

Momentum

AXGN

AXGN on the Momentum factor, by 15 points.

Lower downside

JPM

JPM on Risk Resilience, by 32 points.

Analyst upside

JPM

JPM on implied upside to the consensus price target.

AIQ vs Wall Street

The model and the Street disagree here: AIQ favors AXGN, analyst targets favor JPM. That disagreement is the most useful thing on this page.

MeasureAXGNJPMNote
Implied upside to target+2.1%+15.1%JPM has more room
Target dispersion+20.6%+30.3%Lower is tighter analyst agreement
ConsensusBuyBuyContext, not a primary driver
Analysts covering1126Higher coverage generally improves confidence

The two are measuring different things. The AIQ Score reads current fundamentals, valuation, trend and risk; analyst targets price forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something already priced in — it is worth resolving before acting on either.

Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.

AIQ Agreement Matrix

3 of 6 covered evidence groups favor AXGN. A wide gap backed by one group is a weaker case than a narrow gap backed by five.

Evidence groupFavorsReading
AIQ ScoreEven65 vs 64
FundamentalsAXGNon balancerevenue growth 8.8% vs -7.6%; EPS growth 233.3% vs -27.6%; gross margin 74.2% vs 63.2%; operating margin -5.2% vs 28.2% — AXGN takes 3 of 4 decided legs, not all of them
ValuationAXGNValue 33 vs 10
TechnicalsAXGNPrice vs 50-day 31.6% vs -4.8%; vs 200-day 38% vs 6.6%
Risk ResilienceJPMRisk Resilience 55 vs 87
Analyst expectationsJPMTarget upside 2.1% vs 15.1%

✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of AXGN and JPM and are excluded from the count.

AIQ Decision Stability

Fragile

The conclusion is sensitive to small changes. Treat the lead as provisional and watch the flip conditions below.

  • The AIQ gap is narrow at 1 points. (argues the conclusion is provisional)
  • Only 3 of 6 covered evidence groups agree. (argues the conclusion is provisional)
  • The lead has already changed hands inside the comparison window. (argues the conclusion is provisional)
  • The leader is throwing conflicting signals. (argues the conclusion is provisional)

Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on AXGN.

How the comparison changed

120 daily snapshots · Jun 1 – Nov 18

AXGN lead: Reversed — JPM led by 7 AIQ points 30 sessions ago; AXGN now leads by 1.

Jun 1AXGN leads above the line · JPM leads belowNov 18
Today
AXGN +1
65 vs 64
7 sessions ago
JPM +3
62 vs 65
30 sessions ago
JPM +7
56 vs 63
90 sessions ago
AXGN +1
64 vs 63

The lead changed hands 4 times in this window, most recently on Nov 18 when AXGN moved ahead of JPM.

AIQ Signal Divergence

Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.

AXGNConflicted

5 bullish / 1 bearish / 2 neutral, conflicted

Only AXGN

  • ADX Trend Strengthening — neutral, trend, medium horizon
  • ATR Expansion - Breakout Mode — neutral, volatility, short horizon (5.29%)
  • Keltner Channel Breakout — bullish, volatility, short horizon
JPMConflicted

6 bullish / 1 bearish / 1 neutral, conflicted

Only JPM

  • Bollinger Band Squeeze — neutral, volatility, short horizon (5.9%)
  • Drawdown Recovery Signal — bullish, risk_regime, long horizon (-9.0%)
  • MACD Histogram Expanding Bullish — bullish, momentum, short horizon

Both carry 5 more signals that do not separate them: Golden Cross Active, EMA Ribbon Expansion Bullish, Low Volume Rally Warning, TRIX Bullish Signal, Uptrend Structure Active.

AXGN leads the comparison while carrying a conflicted signal state, which is one reason the stability rating is not higher.

Price vs model alignment

Whether the latest session's price move confirms what the model did over the same session, or contradicts it.

AXGNConfirmed strength

Price and the AIQ Score both moved up over the latest session (price +2.85%, AIQ +3 points).

JPMNo material change

Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price -1.77%, AIQ 0 points).

What would flip this result

A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.

  1. 1JPM closes the Value gap — currently 23 points behind, the largest single contributor to AXGN's edge.
  2. 2JPM's Bollinger Band Squeeze turns directional — it is neutral today and would confirm a change in trend.
  3. 3AXGN's conflicting signal state resolves bearish — it currently carries 5 bullish and 1 bearish rules at once.
  4. 4A market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.

The full evidence

Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.

Fundamentals

AXGN leads on balance
MetricAXGNJPM
Revenue growth (YoY)8.8%-7.6%
EPS growth (YoY)233.3%-27.6%
Gross margin74.2%63.2%
Operating margin-5.2%28.2%
Return on equity (TTM)0.5%4.1%
Debt to equity0.043.32

Performance

AXGN leads 6 of 6 windows
MetricAXGNJPM
1 week (5 sessions)11.8%3.5%
1 month (20 sessions)61.6%1.9%
3 months (63 sessions)13.8%-4.1%
6 months (126 sessions)36.4%16.2%
Year to date70.9%7.4%
1 year (252 sessions)132.2%8%

Technicals

AXGN has the stronger structure
MetricAXGNJPM
RSI (14)69.956.1
ADX (14)41.918
Price vs 50-day31.6%-4.8%
Price vs 200-day38%6.6%
Volatility (1M, annualized)125.5%27.4%

Risk

JPM is the more resilient
MetricAXGNJPM
Beta1.090.78
Sharpe ratio1.610.44
Sortino ratio2.990.61
Max drawdown-33.1%-15.5%
Current drawdown-4.6%-5.2%
Annualized volatility61.3%22.7%
Value at risk (95%)-5%-2.4%

Straight answers

Each answer is regenerated from the current snapshot, not written once and left to age.

Which is better, AXGN or JPM?

On the Algovestiq AIQ Score, AXGN is the stronger of the two as of Nov 18, 2026, scoring 65 against JPM's 64. The edge comes from value and momentum. JPM is not without a case — it holds the better risk resilience profile, which matters more if that is the objective you are optimizing for. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.

Is AXGN or JPM the better buy right now?

AXGN carries the stronger systematic profile as of Nov 18, 2026, and the comparison is rated Fragile — 3 of 6 covered evidence groups agree. A Fragile rating means the conclusion is sensitive: the AIQ gap is narrow at 1 points. Treat the lead as provisional.

Why does the AIQ Score favor AXGN over JPM?

The composite weights Quality, Value, Momentum and Risk Resilience. JPM leads Risk Resilience by 32 points; AXGN leads Value by 23 points; JPM leads Quality by 16 points. Where the two split, the factor with the larger weight carries the result.

Which has more analyst upside, AXGN or JPM?

Analyst price targets imply +2.1% upside for AXGN and +15.1% for JPM, so the Street currently favors JPM. That points the opposite way to the AIQ Score, which favors AXGN. The two are measuring different things: the model reads current fundamentals, valuation, trend and risk; the Street is pricing forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something the analysts have already priced — it is the single most useful row on this page to investigate. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.

Which is better value, AXGN or JPM?

AXGN is the better-valued of the two on the peer-relative Value factor. AXGN on the peer-relative Value factor, by 23 points. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.

Which has stronger growth, AXGN or JPM?

AXGN on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.

Which has stronger momentum, AXGN or JPM?

AXGN on the Momentum factor, by 15 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.

Which is riskier, AXGN or JPM?

JPM is the more resilient of the two, so the other name carries the higher downside risk. JPM on Risk Resilience, by 32 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.

Is AXGN more profitable than JPM?

The profitability evidence is mixed: gross margin 74.2% vs 63.2%; operating margin -5.2% vs 28.2%; ttm roe 0.5% vs 4.1%. Each name leads on one measure, and there is no single profitability composite that resolves the split — which of the two reads as "more profitable" depends on whether you weight pricing power or operating leverage.

Is AXGN's lead over JPM getting stronger or weaker?

AXGN lead: Reversed — JPM led by 7 AIQ points 30 sessions ago; AXGN now leads by 1. This is measured from 120 daily comparison snapshots between 2026-06-01 and 2026-11-18. The lead has changed hands 4 times in that window, most recently on 2026-11-18, when AXGN moved ahead of JPM.

What would change the AXGN vs JPM verdict?

The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: JPM closes the Value gap — currently 23 points behind, the largest single contributor to AXGN's edge; JPM's Bollinger Band Squeeze turns directional — it is neutral today and would confirm a change in trend; AXGN's conflicting signal state resolves bearish — it currently carries 5 bullish and 1 bearish rules at once; a market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.

What do the current signals say about AXGN and JPM?

AXGN: 5 bullish / 1 bearish / 2 neutral, conflicted. JPM: 6 bullish / 1 bearish / 1 neutral, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on AXGN is Golden Cross Active (bullish, long horizon). On JPM it is Golden Cross Active (bullish, long horizon).

Compare AXGN and JPM with others

Continue your research

This page answers which of the two. These answer the questions on either side of it.

How this comparison is scored

The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.

The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.

How to use side-by-side comparison →

This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.